Corentin holds a PhD in astrophysics and joined IBEX in 2019 to optimise the performance of the IBEX software back-end
Kurt leads the securing of grants and is vital in clinical trial planning, certification and marketing communications. Kurt has an MEng in Chemical Engineering and is currently studying for his MBA.
Lisa is passionate about everything Quality and Regulatory, ensuring compliance with applicable medical device regulations, guidance, and standards, whilst staying abreast of changes in the regulatory climate. Lisa is currently studying for a Masters in Regulatory Affairs.
Perry Duffill is VP of Test & Inspection at Nordson Corporation and acts as Nordson non-executive director here at IBEX Innovations. Perry has worked as a senior executive for large multinationals and growth SME’s across three continents. With a specific focus on change management and leading companies into fast-growing profitability, he also has experience in changing…
Alastair is a Partner at IP Group plc, the leading FTSE 250 venture investor. He represents the Group on several commercial-stage health-tech company boards and leads IP Capital, the firm’s co-investment platform, third-party fund management, and advisory division. He has over fifteen years of public and private investment experience and has worked at JPMorgan, Jefferies…
Paul leads the technical development at IBEX and has a strong experimental background, with experience in product development, project management and X-ray physics.
Neil takes primary executive responsibility for the operation of IBEX, and the development and execution of its long-term commercial and technology strategy.
Charles is the non-executive Chairman. He has held senior management positions within a number of quoted companies, most recently at Oxford instruments plc where he was responsible for group business development including M&A activities.